Ironwood Pharmaceuticals (IRWD) PT Lowered to $17 at BTIG
BTIG analyst Timothy Chiang lowered the price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $17.00 (from $21.00) while maintaining a Buy rating.
BTIG analyst Timothy Chiang lowered the price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $17.00 (from $21.00) while maintaining a Buy rating.